Anna G. N.
- Country
- Poland
- Department
- N/A
Research Overview
- Evaluation of Cenobamate as Adjunctive Therapy in Patients Aged 12 and Older with Primary Generalized Tonic-Clonic Seizures: A Randomized, Double-Blind, Placebo-Controlled Study
- Long-term Safety Evaluation of Cenobamate as Adjunctive Therapy in Patients with Primary Generalized Tonic-Clonic Seizures: A Multicenter Open-label Extension Study
- Evaluation of Safety and Efficacy of Cenobamate in Pediatric Patients with Partial-Onset Seizures: An Open-Label Clinical Trial
Data & Insights
Has run more than one trial at 9 of 46 partner sites.
Specializations
Neurological Disorders
This investigator specializes in the treatment of primary generalized tonic-clonic seizures and partial-onset focal seizures, with particular emphasis on therapeutic interventions using novel anticonvulsant medications.
- Epilepsy Management
- Seizure Prevention
- Anticonvulsant Therapy
Focuses on both adult and pediatric populations, including adolescents aged 2-18 years.
Headache Medicine
The investigator demonstrates expertise in migraine prevention, particularly focusing on pediatric and adolescent populations aged 6-17 years.
- Pediatric Migraine Management
- Preventive Treatment Approaches
- Long-term Therapeutic Solutions
Specializes in both episodic and chronic migraine conditions in young patients.
Pediatric Neurology
This investigator has developed specific expertise in pediatric neurological conditions, focusing on age-appropriate therapeutic approaches.
- Child and Adolescent Treatment
- Age-Specific Dosing Strategies
- Long-term Safety Monitoring
Addresses both acute and chronic neurological conditions in young patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.